Back
ESC Premium Access

Effect of bivalirudin vs unfractionated heparin in transcatheter aortic valve implantation with balloon-expandable valves. The BRAVO-3 trial

Session: Poster session 1 - Percutaneous structural heart interventions
Topic: Percutaneous / endovascular treatment
Speaker: Professor A. Linke (Dresden, DE)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Axel Hp Linke

Heart Center - University Hospital Dresden, Dresden (Germany)
3 presentations
0 follower

18 more presentations in this session

Comparison of outcomes between nonagenarian and younger patients undergoing transcatheter aortic valve replacement (TAVR) with the LOTUS valve.

Speaker: Doctor S. Ramkumar (Melbourne, AU)

Access
Abstract
Slides
Like
Thumbnail

Transradial versus the transfemoral approach in alcohol septal ablation

Speaker: Doctor T. Lefevre (Massy, FR)

Access
Abstract
Slides
Like
Thumbnail

Long term follow up after transcatheter tricuspid valve-in-valve replacement using Edwards Sapien XT valve.

Speaker: Doctor R. Scarsini (Verona, IT)

Access
Abstract
Slides
Like
Thumbnail

5 years after percutaneous edge-to-edge mitral valve repair, what has happened?

Speaker: Mr F. Kortlandt (Nieuwegein, NL)

Access
Abstract
Slides
Like
Thumbnail

Is multiparametric FRANCE-2 score better than EuroSCORE II and STS PROM in predicting early mortality after transcatheter aortic valve implantation?

Speaker: Doctor J. Carmo (Carnaxide, PT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 1 - Percutaneous structural heart interventions

Speakers: Professor A. Linke, Doctor S. Ramkumar, Doctor T. Lefevre, Doctor R. Scarsini, Mr F. Kortlandt...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources